The project, titled "Nanoparticle-mediated ocular delivery of novel NAD-boosting small molecules for ophthalmic disease," is conducted in collaboration with a world-leading laboratory in nanotechnology, the Sotiriou Laboratory.
– Developing methods to deliver neuroprotective drugs using nanotechnology is the next exciting step in our work to develop new treatments for several eye diseases, says Pete Williams.